Dutch Medical Center Deploys Genedrive's Rapid Pharmacogenetic Test

04:52 AM EDT, 08/04/2026 (MT Newswires) -- Genedrive's (GDR.L) rapid pharmacogenetic test for the prevention of antibiotic-induced hearing loss in newborns was rolled out at Erasmus MC University Medical Center in Rotterdam, the Netherlands, on Monday. The Genedrive MT-RNR1 ID Kit is in practice at over 20 neonatal intensive care units in the UK and abroad, the London-listed point-of-care pharmacogenetic testing company said Tuesday.